Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?

By Delvigne A.   Carlier C.   Rozenberg S.  

Fertility and Sterility, Vol. 76, Iss. 4, 2001-10 ,pp. : 844-846

Elsevier

Access to resources Recommend Favorite

Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist

By Tavaniotou A.   Albano C.   Smitz J.   Devroey P.  

Fertility and Sterility, Vol. 77, Iss. 4, 2002-04 ,pp. : 733-737

Elsevier

Access to resources Recommend Favorite

A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the ''follicle-stimulating hormone window'' combined with the gonadotropin-releasing hormone antagonist cetrorelix

By de Jong D.   Macklon N.S.   Fauser B.C.J.M.  

Fertility and Sterility, Vol. 73, Iss. 5, 2000-05 ,pp. : 1051-1054

Elsevier

Access to resources Recommend Favorite

Ovarian stimulation in in vitro fertilization with or without the ''long'' gonadotropin-releasing hormone agonist protocol: effect on cycle duration and outcome

By Beloosesky R.   Kol S.   Lightman A.   Itskovitz-Eldor J.  

Fertility and Sterility, Vol. 74, Iss. 1, 2000-07 ,pp. : 166-168

Elsevier

Access to resources Recommend Favorite

Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon)

By de Jong D.   Macklon N.S.   Eijkemans M.J.C.   Mannaerts B.M.J.L.   Coelingh Bennink H.J.T.   Fauser B.C.J.M.   for the Ganirelix Dose-Finding Study Group  

Fertility and Sterility, Vol. 75, Iss. 4, 2001-04 ,pp. : 688-693

Elsevier

Access to resources Recommend Favorite